FindTrial
Sign In

M-CPP and Fenfluramine in Cocaine Addicts - 3

To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000314
Enrollment
0
Registered
1999-09-21
Start date
1994-09-30
Completion date
1999-08-31
Last updated
2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.

Interventions

DRUGM-CPP

Sponsors

VA Office of Research and Development
CollaboratorFED
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
MALE
Age
25 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Hospitalization, arrests, jail, employment, psychiataric symptoms—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026